Publication | Closed Access
Cardiac mortality in users of olmesartan, other angiotensin‐receptor blockers and angiotensin‐converting enzyme inhibitors
13
Citations
5
References
2013
Year
The results of this well-powered study do not raise concerns for the risk of SCD or death from all causes among olmesartan users in comparison with users of other ARBs or ACE inhibitors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1